Nov 24, 2024 · Diffuse hepatocellular disease refers to a broad category of liver conditions that affect the entire liver rather than localized areas. These diseases often disrupt liver function and structure. Imaging tests play a role in diagnosis, monitoring, and treatment planning.

The most significant side effects of end-stage liver disease are portal hypertension and primary liver cancer (hepatocellular carcinoma). Complications of these two conditions are the leading causes of hospitalization and death in people with cirrhosis and liver failure.

Apr 4, 2024 · Nonalcoholic fatty liver disease, often called NAFLD, is a liver problem that affects people who drink little to no alcohol. In NAFLD, too much fat builds up in the liver. It is seen most often in people who are overweight or obese.

Mar 21, 2018 · At an early stage of cirrhosis, the liver may appear normal. With disease progression, heterogeneity and surface nodularity are observed. Because of the unique ability of the liver to regenerate in cirrhosis, the liver harbors a spectrum of hepatocellular nodules, most of which are regenerative.

Current and developing MRI techniques for detecting and quantifying biomarkers of diffuse liver disease are poised to provide game changing technology for diagnosis, monitoring of disease, and for therapy development.

Aug 27, 2016 · Diffuse disease occurs as the hepatocytes are damaged and liver function decreases. Disease processes that affect the liver diffusely include infections, fatty infiltration, and liver fibrosis. The sonographic appearance of the liver varies depending on the cause.

Mar 21, 2018 · This chapter will describe the most common imaging features of hepatic metabolic and storage diseases, including overload with fat, iron, copper, and amyloid and diffuse neoplastic diseases. We also discuss focal and diffuse infectious and inflammatory hepatic diseases.

Mar 17, 2023 · Learn about diffuse vascular liver disease causing liver parenchyma alteration. Non-alcoholic fatty liver disease (NAFLD) represents a global epidemic which is now estimated to affect up to 25% of the world’s adult population.

Characteristic changes in attenuation on CT, signal intensity on MR, and enhancing features can be used to diagnose specific diffuse diseases. This article focuses on the current role of imaging in the detection and characterization of diffuse liver disorders.

Feb 13, 2024 · Finding the cause of liver damage and how bad it is help guide treatment. Your healthcare professional starts with a health history and complete physical exam. Your healthcare professional may then suggest: Blood tests. A group of blood tests called liver function tests can diagnose liver disease.